Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

WCLC 2025 | What is the role of local therapy in oligometastatic NSCLC?

Qing Zhou, MD, PhD, Guangdong Lung Cancer Institute, Guangzhou, China, discusses the significance of combining local treatment with systemic treatment to improve outcomes for patients with lung cancer, highlighting the potential for overcoming resistance and achieving long-term survival. Local treatments such as radiotherapy and surgery can be effective when combined with systemic therapies, leading to improved survival rates. This interview took place at 2025 World Conference on Lung Cancer (WCLC) in Barcelona, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

I think for this population, the local treatment is very important. For example, the radiotherapy, the surgery. So we must combine the local treatment and the systemic treatment together to try to cure this population. Because if we combine this radiotherapy or surgery, the local treatment together with the systemic we can overcome the resistance and overcome the oligometastatic progression and the local persistence to give the patient very long survival...

I think for this population, the local treatment is very important. For example, the radiotherapy, the surgery. So we must combine the local treatment and the systemic treatment together to try to cure this population. Because if we combine this radiotherapy or surgery, the local treatment together with the systemic we can overcome the resistance and overcome the oligometastatic progression and the local persistence to give the patient very long survival.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...